COPD合并GERD的研究现状

doi:10.3969/j.issn.1671-7171.2017.03.029

摘要
图/表
参考文献
相关文章 (15)

[1] El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review[J].Gut.2014. 63(6): 871-880.
[2] Shay SS, Bomeli S, Richter J. Multichannel intraluminal impedance accurately detects fasting, recumbent reflux events and their clearing[J].Am J Physiol Gastrointest Liver Physiol,2002, 283(2): G376-G383.
[3] Terada K, Muro S, Sato S,et al. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation[J].Thorax,2008,63(11): 951-955.
[4] Ingebrigtsen TS, Marott JL, Vestbo J, et al. Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease[J].Respirology,2015. 20(1): 101-107.
[5] Lin YH, Tsai CL, Chien LN, et al. Newly diagnosed gastroesophageal reflux disease increased the risk of acute exacerbation of chronic obstructive pulmonary disease during the first year following diagnosis-a nationwide population-based cohort study[J].Int J Clin Pract,2015,69(3): 350-357.
[6] Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease[J].N Engl J Med,2010. 363(12): 1128-1138.
[7] Figueroa JD, Terry MB, Gammon MD, et al. Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression[J].Cancer Causes Control,2009,20(3): 361-368.
[8] Emerenziani S, Ribolsi M, Pasqualetti P, et al. Measurement of acid exposure of proximal esophagus: a better tool for diagnosing non-erosive reflux disease[J].Neurogastroenterol Motil,2011, 23(8): 711-e324.
[9] Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease[J].Am J Gastroenterol,2013. 108(3): 308-328.
[10] Bolier EA, Kessing BF, Smout AJ, et al. Systematic review: questionnaires for assessment of gastroesophageal reflux disease[J].Dis Esophagus,2015,28(2): 105-120.
[11] Sakae TM, Pizzichini MM, Teixeira PJ, et al. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis[J].J Bras Pneumol,2013,39(3): 259-271.
[12] Martinez CH, Okajima Y, Murray S, et al. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort[J].Respir Res,2014,15: 62.
[13] Sole ML, Conrad J, Bennett M, et al. Pepsin and amylase in oral and tracheal secretions: a pilot study[J].Am J Crit Care,2014, 23(4): 334-338.
[14] Lee AL, Button BM, Denehy L, et al. Exhaled Breath Condensate Pepsin: Potential Noninvasive Test for Gastroesophageal Reflux in COPD and Bronchiectasis[J].Respir Care,2015, 60(2): 244-250.
[15] Gadel AA, Mostafa M, Younis A, et al. Esophageal motility pattern and gastro-esophageal reflux in chronic obstructive pulmonary disease[J].Hepatogastroenterology,2012, 59(120): 2498-2502.
[16] Kim J, Lee JH, Kim Y, et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study[J].BMC Pulm Med,2013,13: 51.
[17] Cui Y, Devillier P, Kuang X, et al. Tiotropium reduction of lung inflammation in a model of chronic gastro-oesophageal reflux[J].Eur Respir J,2010. 35(6): 1370-1376.
[18] Del Grande LM, Herbella FA, Bigatao AM,et al. Pathophysiology of Gastroesophageal Reflux in Patients with Chronic Pulmonary Obstructive Disease Is Linked to an Increased Transdiaphragmatic Pressure Gradient and not to a Defective Esophagogastric Barrier[J].J Gastrointest Surg,2015, 20(1):104-110.
[19] Dicpinigaitis PV, Morice AH, Birring SS, et al. Antitussive drugs--past, present, and future[J].Pharmacol Rev,2014, 66(2): 468-512.
[20] Robertson AG, Ward C, Pearson JP, et al. Lung transplantation, gastroesophageal reflux, and fundoplication[J].Ann Thorac Surg,2010, 89(2): 653-660.
[21] Grabowski M, Kasran A, Seys S, et al. Pepsin and bile acids in induced sputum of chronic cough patients[J].Respir Med,2011, 105(8): 1257-1261.
[22] Cheng YM, Cao AL, Zheng JP, et al. Airway hyperresponsiveness induced by repeated esophageal infusion of HCl in guinea pigs[J].Am J Respir Cell Mol Biol,2014, 51(5): 701-708.
[23] Uzun S, Djamin RS, Kluytmans JA, et al. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial[J].Lancet Respir Med,2014. 2(5): 361-368.
[24] Ament PW, Dicola DB, James ME. Reducing adverse effects of proton pump inhibitors[J].Am Fam Physician,2012, 86(1): 66-70.
[25] Filion KB, Chateau D, Targownik LE, et al. Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis[J].Gut,2014,63(4): 552-558.
[26] Reimer C. Safety of long-term PPI therapy[J].Best Pract Res Clin Gastroenterol,2013,27(3): 443-454.
[27] Hershcovici T, Fass R. Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy[J].Drugs,2011,71(18): 2381-2389.
[28] Hayat JO, Gabieta-Somnez S, Yazaki E, et al. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease[J].Gut,2015,64(3): 373-380.
[29] Benson VS, Mullerova H, Vestbo J, et al. Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease[J].Respir Med,2015, 109(9): 1147-1154.
[30] Tsai CL, Lin YH, Wang MT, et al. Gastro-oesophageal reflux disease increases the risk of intensive care unit admittance and mechanical ventilation use among patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study[J].Crit Care,2015, 19: 110.